Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi IBEX 35 UCITS ETF Dist

LYXIB · FR0010251744 · class Dist · EUR · domicile France
Equity · Spain · Large capSFDR art. 6
Index tracked: IBEX 35 Net Return Index
TER
0.30%+ trans. 0.14%
Fund size
451 m EUR
Tracking difference
+0.57%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Mixed (acc. and/or dist.)
Launch 19 Sept 2018 · costs from the KID as of 2 Sept 2026 · 36 securities held · 1 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund is a passively managed index-based UCITS. The Fund's objective is to replicate, both upwards and downwards, the performance of the IBEX 35 Net Return Index (net dividends reinvested) (the "Benchmark"), denominated in euro (EUR), the main Spanish stock exchange index, while minimising the tracking error between the Fund's performance and that of the Benchmark. The expected level of the Tracking Error under normal market conditions is indicated in the Fund prospectus. The Bolsa Madrid website…

Performance since series start (in euro) — base 100

1 Oct 20128 Sept 2026 · dividends reinvested where declared by the issuer
201320152017201920212023202542598421
High 425 (7 Aug 2026) · low 98 (8 Nov 2012) · last 421. Past performance is not indicative of future results.

Returns in euro

1 year+38.8%
3 years+137.9%
5 years+168.2%
10 years+212.4%
Since series start+321.0%

Risk · 1 / 3 / 5 years

Volatility (ann.)16.12%15.49%16.48%
Max drawdown−9.66%−12.50%−20.31%
Sharpe1.801.550.99
Sortino2.802.231.39
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LYXIB · FR00102517441
RebalixLYXIB · FR0010251744 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
YearFundIndexTD
2025+54.77%+54.16%+0.60%
2024+19.54%+18.99%+0.55%
2023+27.60%+27.03%+0.57%
2022−2.33%−2.70%+0.37%
2021+10.36%+10.28%+0.08%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 36 securities · top-10 weight = 77.6%
Top holdingsWeight
BANCO SANTANDER SA MADRID18.1%
BANCO BILBAO VIZCAYA ARGENTA13.7%
IBERDROLA SA13.2%
INDUSTRIA DE DISENO TEXTIL10.5%
CAIXABANK SA7.2%
FERROVIAL SE MADRID3.6%
AENA SME SA3.1%
REPSOL SA3.0%
ACS ACTIVIDADES CONS Y SERV2.8%
AMADEUS IT GROUP SA2.5%
Countries (% of fund)
Spain100.0%
Sectors (% of fund)
Financials43.9%Utilities19.0%Consumer Discretionary13.1%Industrials12.7%Communication Services3.7%

Listing venues

ESMA register (FIRDS) and official exchange lists
· BME (Bolsa de Madrid)
+ 12 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR0010251744/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0010251744/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR0010251744/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/FR0010251744
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · LYXIB · FR00102517442